BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin L, Wisor J, Shiba T, Taheri S, Yanai K, Wurts S, Lin X, Vitaterna M, Takahashi J, Lovenberg T, Koehl M, Uhl G, Nishino S, Mignot E. Measurement of hypocretin/orexin content in the mouse brain using an enzyme immunoassay: the effect of circadian time, age and genetic background. Peptides 2002;23:2203-11. [DOI: 10.1016/s0196-9781(02)00251-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Desarnaud F, Murillo-Rodriguez E, Lin L, Xu M, Gerashchenko D, Shiromani SN, Nishino S, Mignot E, Shiromani PJ. The diurnal rhythm of hypocretin in young and old F344 rats. Sleep 2004;27:851-6. [PMID: 15453542 DOI: 10.1093/sleep/27.5.851] [Cited by in Crossref: 65] [Cited by in F6Publishing: 58] [Article Influence: 3.6] [Reference Citation Analysis]
2 Provensi G, Costa A, Izquierdo I, Blandina P, Passani MB. Brain histamine modulates recognition memory: possible implications in major cognitive disorders. Br J Pharmacol 2020;177:539-56. [PMID: 30129226 DOI: 10.1111/bph.14478] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
3 Liu M, Thankachan S, Kaur S, Begum S, Blanco-Centurion C, Sakurai T, Yanagisawa M, Neve R, Shiromani PJ. Orexin (hypocretin) gene transfer diminishes narcoleptic sleep behavior in mice. Eur J Neurosci 2008;28:1382-93. [PMID: 18973565 DOI: 10.1111/j.1460-9568.2008.06446.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
4 Guevarra JT, Hiensch R, Varga AW, Rapoport DM. Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility. Nat Sci Sleep 2020;12:709-19. [PMID: 33117007 DOI: 10.2147/NSS.S264140] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Berteotti C, Lo Martire V, Alvente S, Bastianini S, Bombardi C, Matteoli G, Ohtsu H, Lin JS, Silvani A, Zoccoli G. Orexin/Hypocretin and Histamine Cross-Talk on Hypothalamic Neuron Counts in Mice. Front Neurosci 2021;15:660518. [PMID: 34093114 DOI: 10.3389/fnins.2021.660518] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Feng XM, Mi WL, Xia F, Mao-Ying QL, Jiang JW, Xiao S, Wang ZF, Wang YQ, Wu GC. Involvement of spinal orexin A in the electroacupuncture analgesia in a rat model of post-laparotomy pain. BMC Complement Altern Med 2012;12:225. [PMID: 23173601 DOI: 10.1186/1472-6882-12-225] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
7 Feng P, Vurbic D, Wu Z, Hu Y, Strohl KP. Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine. J Psychopharmacol 2008;22:784-91. [PMID: 18753273 DOI: 10.1177/0269881106082899] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
8 Azeez IA, Igado OO, Olopade JO. An overview of the orexinergic system in different animal species. Metab Brain Dis 2021. [PMID: 34224065 DOI: 10.1007/s11011-021-00761-0] [Reference Citation Analysis]
9 Yeoh JW, James MH, Adams CD, Bains JS, Sakurai T, Aston-Jones G, Graham BA, Dayas CV. Activation of lateral hypothalamic group III metabotropic glutamate receptors suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin/hypocretin cells. Neuropharmacology 2019;154:22-33. [PMID: 30253175 DOI: 10.1016/j.neuropharm.2018.09.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
10 Honda M, Eriksson KS, Zhang S, Tanaka S, Lin L, Salehi A, Hesla PE, Maehlen J, Gaus SE, Yanagisawa M, Sakurai T, Taheri S, Tsuchiya K, Honda Y, Mignot E. IGFBP3 colocalizes with and regulates hypocretin (orexin). PLoS One 2009;4:e4254. [PMID: 19158946 DOI: 10.1371/journal.pone.0004254] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
11 Guan Z, Vgontzas AN, Bixler EO, Fang J. Sleep is increased by weight gain and decreased by weight loss in mice. Sleep 2008;31:627-33. [PMID: 18517033 DOI: 10.1093/sleep/31.5.627] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
12 Shan L, Dauvilliers Y, Siegel JM. Interactions of the histamine and hypocretin systems in CNS disorders. Nat Rev Neurol 2015;11:401-13. [PMID: 26100750 DOI: 10.1038/nrneurol.2015.99] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 8.0] [Reference Citation Analysis]
13 Nixon JP, Mavanji V, Butterick TA, Billington CJ, Kotz CM, Teske JA. Sleep disorders, obesity, and aging: the role of orexin. Ageing Res Rev 2015;20:63-73. [PMID: 25462194 DOI: 10.1016/j.arr.2014.11.001] [Cited by in Crossref: 61] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
14 Gompf HS, Aston-Jones G. Role of orexin input in the diurnal rhythm of locus coeruleus impulse activity. Brain Res 2008;1224:43-52. [PMID: 18614159 DOI: 10.1016/j.brainres.2008.05.060] [Cited by in Crossref: 55] [Cited by in F6Publishing: 55] [Article Influence: 3.9] [Reference Citation Analysis]
15 Anaclet C, Parmentier R, Ouk K, Guidon G, Buda C, Sastre JP, Akaoka H, Sergeeva OA, Yanagisawa M, Ohtsu H, Franco P, Haas HL, Lin JS. Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J Neurosci 2009;29:14423-38. [PMID: 19923277 DOI: 10.1523/JNEUROSCI.2604-09.2009] [Cited by in Crossref: 131] [Cited by in F6Publishing: 86] [Article Influence: 10.1] [Reference Citation Analysis]